Glucosamine salts: Resolving ambiguities over the market-based compositions

Subash Chandra Sahoo, Anjana Tharalekshmy, Seik Weng Ng, Pance Naumov

Research output: Contribution to journalArticle

Abstract

The neutral form of glucosamine, C 6H 13NO 5, one the most effective and most widely used over-the-counter health supplements for the relief of osteoarthritis, is very unstable in air. It is marketed as chloride and sulfate salts. Unlike the stable glucosamine chloride, direct use in pharmaceutical formulations of the sulfate, ostensibly the physiologically more active form, is hindered by its strong hygroscopicity. Copious patent literature exists describing methods for stabilization of the sulfate by converting it into double and/or mixed salts, usually with alkaline or earth alkaline sulfates and chlorides. Aiming to unravel the structures of the alleged double/mixed salts, we attempted synthesis of the stabilized forms of the sulfate following literature procedures. Our repeated attempts did not yield true glucosamine sulfate or any real (in the chemical sense) double or mixed salts. Instead, Fourier transform infrared spectroscopy, powder X-ray diffraction, thermogravimetric analysis, and elemental analyses consistently showed that physical mixtures of the stable glucosamine chloride, which has a strong propensity to crystallize out from solutions, and the respective alkaline salts are obtained in all cases. Expectedly, these mixtures were non-hygroscopic. The analysis of the commercially available sample of "glucosamine sulfate" showed that it is a mixture of glucosamine chloride and K 2SO 4, in accordance with the above conclusions. By using a simple ion exchange in glucosamine chloride, we devised a simple method to generate glucosamine sulfate. As anticipated, the latter is a very hygroscopic powder in the solid state and is chemically moderately unstable in solution. Along with the conclusions based on the products obtained following published procedures, reaction of this compound with alkali chlorides readily affords the (non-hygroscopic) glucosamine chloride in a mixture with the respective alkali sulfates. We are tempted to conclude that the alleged "stabilization" of glucosamine sulfate by formation of double/mixed salts is (in the chemical sense) misleading. We believe that these compounds have probably never been obtained, and the related published synthetic procedures should be reinvestigated. The conclusions of this study could have important implications on the effective amount of the active ingredient required to achieve physiological activity, because such "stabilized" mixtures contain less than the optimal amount of the physiologically active ingredient, which could also have some commercial implications.

Original languageEnglish (US)
Pages (from-to)5148-5154
Number of pages7
JournalCrystal Growth and Design
Volume12
Issue number10
DOIs
StatePublished - Oct 3 2012

Fingerprint

Glucosamine
ambiguity
sulfates
Salts
Chlorides
salts
chlorides
Sulfates
Chemical analysis
Alkalies
ingredients
alkalies
Stabilization
stabilization
hygroscopicity
patents
supplements
Powders
X ray powder diffraction
Drug products

ASJC Scopus subject areas

  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics

Cite this

Glucosamine salts : Resolving ambiguities over the market-based compositions. / Sahoo, Subash Chandra; Tharalekshmy, Anjana; Ng, Seik Weng; Naumov, Pance.

In: Crystal Growth and Design, Vol. 12, No. 10, 03.10.2012, p. 5148-5154.

Research output: Contribution to journalArticle

Sahoo, Subash Chandra ; Tharalekshmy, Anjana ; Ng, Seik Weng ; Naumov, Pance. / Glucosamine salts : Resolving ambiguities over the market-based compositions. In: Crystal Growth and Design. 2012 ; Vol. 12, No. 10. pp. 5148-5154.
@article{c929af151284498aabe277e54256ee69,
title = "Glucosamine salts: Resolving ambiguities over the market-based compositions",
abstract = "The neutral form of glucosamine, C 6H 13NO 5, one the most effective and most widely used over-the-counter health supplements for the relief of osteoarthritis, is very unstable in air. It is marketed as chloride and sulfate salts. Unlike the stable glucosamine chloride, direct use in pharmaceutical formulations of the sulfate, ostensibly the physiologically more active form, is hindered by its strong hygroscopicity. Copious patent literature exists describing methods for stabilization of the sulfate by converting it into double and/or mixed salts, usually with alkaline or earth alkaline sulfates and chlorides. Aiming to unravel the structures of the alleged double/mixed salts, we attempted synthesis of the stabilized forms of the sulfate following literature procedures. Our repeated attempts did not yield true glucosamine sulfate or any real (in the chemical sense) double or mixed salts. Instead, Fourier transform infrared spectroscopy, powder X-ray diffraction, thermogravimetric analysis, and elemental analyses consistently showed that physical mixtures of the stable glucosamine chloride, which has a strong propensity to crystallize out from solutions, and the respective alkaline salts are obtained in all cases. Expectedly, these mixtures were non-hygroscopic. The analysis of the commercially available sample of {"}glucosamine sulfate{"} showed that it is a mixture of glucosamine chloride and K 2SO 4, in accordance with the above conclusions. By using a simple ion exchange in glucosamine chloride, we devised a simple method to generate glucosamine sulfate. As anticipated, the latter is a very hygroscopic powder in the solid state and is chemically moderately unstable in solution. Along with the conclusions based on the products obtained following published procedures, reaction of this compound with alkali chlorides readily affords the (non-hygroscopic) glucosamine chloride in a mixture with the respective alkali sulfates. We are tempted to conclude that the alleged {"}stabilization{"} of glucosamine sulfate by formation of double/mixed salts is (in the chemical sense) misleading. We believe that these compounds have probably never been obtained, and the related published synthetic procedures should be reinvestigated. The conclusions of this study could have important implications on the effective amount of the active ingredient required to achieve physiological activity, because such {"}stabilized{"} mixtures contain less than the optimal amount of the physiologically active ingredient, which could also have some commercial implications.",
author = "Sahoo, {Subash Chandra} and Anjana Tharalekshmy and Ng, {Seik Weng} and Pance Naumov",
year = "2012",
month = "10",
day = "3",
doi = "10.1021/cg301276y",
language = "English (US)",
volume = "12",
pages = "5148--5154",
journal = "Crystal Growth and Design",
issn = "1528-7483",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Glucosamine salts

T2 - Resolving ambiguities over the market-based compositions

AU - Sahoo, Subash Chandra

AU - Tharalekshmy, Anjana

AU - Ng, Seik Weng

AU - Naumov, Pance

PY - 2012/10/3

Y1 - 2012/10/3

N2 - The neutral form of glucosamine, C 6H 13NO 5, one the most effective and most widely used over-the-counter health supplements for the relief of osteoarthritis, is very unstable in air. It is marketed as chloride and sulfate salts. Unlike the stable glucosamine chloride, direct use in pharmaceutical formulations of the sulfate, ostensibly the physiologically more active form, is hindered by its strong hygroscopicity. Copious patent literature exists describing methods for stabilization of the sulfate by converting it into double and/or mixed salts, usually with alkaline or earth alkaline sulfates and chlorides. Aiming to unravel the structures of the alleged double/mixed salts, we attempted synthesis of the stabilized forms of the sulfate following literature procedures. Our repeated attempts did not yield true glucosamine sulfate or any real (in the chemical sense) double or mixed salts. Instead, Fourier transform infrared spectroscopy, powder X-ray diffraction, thermogravimetric analysis, and elemental analyses consistently showed that physical mixtures of the stable glucosamine chloride, which has a strong propensity to crystallize out from solutions, and the respective alkaline salts are obtained in all cases. Expectedly, these mixtures were non-hygroscopic. The analysis of the commercially available sample of "glucosamine sulfate" showed that it is a mixture of glucosamine chloride and K 2SO 4, in accordance with the above conclusions. By using a simple ion exchange in glucosamine chloride, we devised a simple method to generate glucosamine sulfate. As anticipated, the latter is a very hygroscopic powder in the solid state and is chemically moderately unstable in solution. Along with the conclusions based on the products obtained following published procedures, reaction of this compound with alkali chlorides readily affords the (non-hygroscopic) glucosamine chloride in a mixture with the respective alkali sulfates. We are tempted to conclude that the alleged "stabilization" of glucosamine sulfate by formation of double/mixed salts is (in the chemical sense) misleading. We believe that these compounds have probably never been obtained, and the related published synthetic procedures should be reinvestigated. The conclusions of this study could have important implications on the effective amount of the active ingredient required to achieve physiological activity, because such "stabilized" mixtures contain less than the optimal amount of the physiologically active ingredient, which could also have some commercial implications.

AB - The neutral form of glucosamine, C 6H 13NO 5, one the most effective and most widely used over-the-counter health supplements for the relief of osteoarthritis, is very unstable in air. It is marketed as chloride and sulfate salts. Unlike the stable glucosamine chloride, direct use in pharmaceutical formulations of the sulfate, ostensibly the physiologically more active form, is hindered by its strong hygroscopicity. Copious patent literature exists describing methods for stabilization of the sulfate by converting it into double and/or mixed salts, usually with alkaline or earth alkaline sulfates and chlorides. Aiming to unravel the structures of the alleged double/mixed salts, we attempted synthesis of the stabilized forms of the sulfate following literature procedures. Our repeated attempts did not yield true glucosamine sulfate or any real (in the chemical sense) double or mixed salts. Instead, Fourier transform infrared spectroscopy, powder X-ray diffraction, thermogravimetric analysis, and elemental analyses consistently showed that physical mixtures of the stable glucosamine chloride, which has a strong propensity to crystallize out from solutions, and the respective alkaline salts are obtained in all cases. Expectedly, these mixtures were non-hygroscopic. The analysis of the commercially available sample of "glucosamine sulfate" showed that it is a mixture of glucosamine chloride and K 2SO 4, in accordance with the above conclusions. By using a simple ion exchange in glucosamine chloride, we devised a simple method to generate glucosamine sulfate. As anticipated, the latter is a very hygroscopic powder in the solid state and is chemically moderately unstable in solution. Along with the conclusions based on the products obtained following published procedures, reaction of this compound with alkali chlorides readily affords the (non-hygroscopic) glucosamine chloride in a mixture with the respective alkali sulfates. We are tempted to conclude that the alleged "stabilization" of glucosamine sulfate by formation of double/mixed salts is (in the chemical sense) misleading. We believe that these compounds have probably never been obtained, and the related published synthetic procedures should be reinvestigated. The conclusions of this study could have important implications on the effective amount of the active ingredient required to achieve physiological activity, because such "stabilized" mixtures contain less than the optimal amount of the physiologically active ingredient, which could also have some commercial implications.

UR - http://www.scopus.com/inward/record.url?scp=84867027674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867027674&partnerID=8YFLogxK

U2 - 10.1021/cg301276y

DO - 10.1021/cg301276y

M3 - Article

AN - SCOPUS:84867027674

VL - 12

SP - 5148

EP - 5154

JO - Crystal Growth and Design

JF - Crystal Growth and Design

SN - 1528-7483

IS - 10

ER -